Succimer and the Reduction of Tissue Lead in Juvenile Monkeys
- 1 August 2000
- journal article
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 166 (3) , 230-240
- https://doi.org/10.1006/taap.2000.8973
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- The Treatment of Lead‐exposed Children (TLC) trial: design and recruitment for a study of the effect of oral chelation on growth and development in toddlersPaediatric and Perinatal Epidemiology, 1998
- Plasma and Blood Lead Concentrations, Lead Absorption, and Lead Excretion in Nonhuman PrimatesToxicology and Applied Pharmacology, 1996
- Role of chelating agents for prevention, intervention, and treatment of exposures to toxic metals.Environmental Health Perspectives, 1995
- Combined Therapeutic Potential of meso-2,3-Dimercaptosuccinic Acid and Calcium Disodium Edetate on the Mobilization and Distribution of Lead in Experimental Lead Intoxication in RatsFundamental and Applied Toxicology, 1995
- Pharmacokinetics of meso-2,3- dimercaptosuccinic acid in patients with lead poisoning and in healthy adultsThe Journal of Pediatrics, 1994
- Efficacy of oral meso-2,3- dimercaptosuccinic acid therapy for low-level childhood plumbismThe Journal of Pediatrics, 1994
- Controlled study of meso-2,3-dimercaptosuccinic acid for the management of childhood lead intoxicationThe Journal of Pediatrics, 1992
- BAL, EDTA, DMSA and DMPS in the Treatment of Lead Poisoning in ChildrenJournal of Toxicology: Clinical Toxicology, 1992
- MESO-2,3-Dimercaptosuccinic Acid: Chemical, Pharmacological and Toxicological Properties of an Orally Effective Metal Chelating AgentAnnual Review of Pharmacology and Toxicology, 1990
- Dose-response study of oral 2,3-dimercaptosuccinic acid in children with elevated blood lead concentrationsThe Journal of Pediatrics, 1988